Strs Ohio Takes $1.08 Million Position in Docusign Inc. $DOCU

Key Points

• Strs Ohio has made a new investment of approximately $1.08 million in DocuSign Inc., acquiring 13,290 shares of the company during the first quarter of the year.
• Several institutional investors have recently increased their holdings in DocuSign, with Hedge funds owning 77.64% of the company's stock.
• DocuSign's stock has received multiple price target increases from various research firms, with a current consensus rating of "Hold" and an average price target of $94.14.

Strs Ohio bought a new stake in shares of Docusign Inc. (NASDAQ:DOCU - Free Report) in the first quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor bought 13,290 shares of the company's stock, valued at approximately $1,082,000.

A number of other institutional investors and hedge funds have also added to or reduced their stakes in the company. American Century Companies Inc. boosted its holdings in shares of Docusign by 3.1% during the 1st quarter. American Century Companies Inc. now owns 5,477,758 shares of the company's stock worth $445,890,000 after buying an additional 162,299 shares in the last quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC lifted its holdings in shares of Docusign by 18.6% in the 1st quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 2,028,505 shares of the company's stock worth $165,120,000 after purchasing an additional 318,698 shares in the last quarter. Wellington Management Group LLP lifted its holdings in shares of Docusign by 372.5% in the 1st quarter. Wellington Management Group LLP now owns 1,826,949 shares of the company's stock worth $148,714,000 after purchasing an additional 1,440,269 shares in the last quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC lifted its holdings in shares of Docusign by 3.0% in the 4th quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC now owns 1,709,807 shares of the company's stock worth $153,780,000 after purchasing an additional 50,440 shares in the last quarter. Finally, Charles Schwab Investment Management Inc. lifted its holdings in shares of Docusign by 6.7% in the 1st quarter. Charles Schwab Investment Management Inc. now owns 1,431,901 shares of the company's stock worth $116,557,000 after purchasing an additional 89,948 shares in the last quarter. Institutional investors and hedge funds own 77.64% of the company's stock.

Docusign Stock Performance

NASDAQ DOCU traded down $0.42 during trading hours on Friday, hitting $84.59. The company had a trading volume of 4,516,106 shares, compared to its average volume of 3,404,911. Docusign Inc. has a 52 week low of $57.58 and a 52 week high of $107.86. The firm has a market capitalization of $17.01 billion, a price-to-earnings ratio of 63.60, a PEG ratio of 4.46 and a beta of 1.02. The firm has a 50 day simple moving average of $76.39 and a 200 day simple moving average of $79.30.

Docusign (NASDAQ:DOCU - Get Free Report) last issued its quarterly earnings data on Thursday, September 4th. The company reported $0.92 EPS for the quarter, topping the consensus estimate of $0.84 by $0.08. Docusign had a return on equity of 14.01% and a net margin of 9.08%.The company had revenue of $800.64 million during the quarter, compared to analyst estimates of $780.35 million. During the same quarter in the previous year, the firm earned $0.97 earnings per share. Docusign's revenue was up 8.8% on a year-over-year basis. Docusign has set its Q3 2026 guidance at EPS. FY 2026 guidance at EPS. On average, research analysts forecast that Docusign Inc. will post 1.17 earnings per share for the current year.

Docusign announced that its Board of Directors has authorized a stock buyback plan on Thursday, June 5th that authorizes the company to repurchase $1.00 billion in shares. This repurchase authorization authorizes the company to reacquire up to 6.6% of its stock through open market purchases. Stock repurchase plans are typically a sign that the company's board believes its stock is undervalued.

Insider Buying and Selling

In other Docusign news, Director Anna Marrs sold 728 shares of the business's stock in a transaction that occurred on Monday, September 15th. The stock was sold at an average price of $80.30, for a total value of $58,458.40. Following the completion of the sale, the director owned 10,799 shares in the company, valued at approximately $867,159.70. The trade was a 6.32% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Also, Director James A. Beer sold 450 shares of the business's stock in a transaction that occurred on Tuesday, September 16th. The shares were sold at an average price of $81.28, for a total value of $36,576.00. Following the completion of the sale, the director owned 14,199 shares of the company's stock, valued at $1,154,094.72. The trade was a 3.07% decrease in their position. The disclosure for this sale can be found here. Insiders have sold a total of 82,533 shares of company stock worth $6,598,028 over the last ninety days. Corporate insiders own 1.01% of the company's stock.

Wall Street Analyst Weigh In

DOCU has been the topic of a number of recent research reports. Piper Sandler increased their target price on Docusign from $85.00 to $90.00 and gave the stock a "neutral" rating in a report on Friday, September 5th. Wells Fargo & Company raised their target price on Docusign from $80.00 to $85.00 and gave the company an "equal weight" rating in a research report on Friday, September 5th. Royal Bank Of Canada raised their target price on Docusign from $90.00 to $95.00 and gave the company a "sector perform" rating in a research report on Friday, September 5th. Bank of America raised their target price on Docusign from $85.00 to $102.00 and gave the company a "neutral" rating in a research report on Friday, September 5th. Finally, Argus reaffirmed a "hold" rating on shares of Docusign in a research report on Monday, September 8th. One equities research analyst has rated the stock with a Strong Buy rating, four have assigned a Buy rating and fourteen have assigned a Hold rating to the company's stock. Based on data from MarketBeat.com, Docusign has an average rating of "Hold" and an average price target of $94.14.

About Docusign

DocuSign, Inc provides electronic signature solution in the United States and internationally. The company provides e-signature solution that enables sending and signing of agreements on various devices; Contract Lifecycle Management (CLM), which automates workflows across the entire agreement process; Document Generation streamlines the process of generating new, custom agreements; and Gen for Salesforce, which allows sales representatives to automatically generate agreements with a few clicks from within Salesforce.